Friday, August 22, 2008

NEW Clinical Drug Trials listed on CenterWatch.com

CenterWatch_Header

You are receiving this email because you registered your email address with CenterWatch to stay informed about clincial trials. New clinical trials have been posted on the CenterWatch web site www.centerwatch.com in your areas of interest and geographic locations.

Investigational Oral Medication for RRMS
Burnaby, BC, CANADA

Investigational Oral Medication for RRMS
Gatineau, QC, CANADA

Investigational Oral Medication for RRMS
Sherbrooke, QC, CANADA

Investigational Oral Medication for RRMS
Edmonton, AB, Canada

Investigational Oral Medication for RRMS
Montreal, QC, Canada

Investigational Oral Medication for RRMS
Halifax, NS, CANADA

Investigational Oral Medication for RRMS
Levis, PQ, CANADA

Investigational Oral Medication for RRMS
Montreal, QC, CANADA

Investigational Oral Medication for RRMS
Ottawa, ON, CANADA

Investigational Oral Medication for RRMS
Quebec, QC, CANADA

Investigational Oral Medication for RRMS
Regina, SK, CANADA

Investigational Oral Medication for RRMS
Birmingham, AL

Investigational Oral Medication for RRMS
Cullman, AL

Investigational Oral Medication for RRMS
Huntsville, AL

Investigational Oral Medication for RRMS
Gilbert, AZ

Investigational Oral Medication for RRMS
Phoenix, AZ

Investigational Oral Medication for RRMS
Phoenix, AZ

Investigational Oral Medication for RRMS
Burlington, VT

Investigational Oral Medication for RRMS
Seattle, WA

Investigational Oral Medication for RRMS
Seattle, WA

Investigational Oral Medication for RRMS
Tacoma, WA

Investigational Oral Medication for RRMS
Madison, WI

Investigational Oral Medication for RRMS
Milwaukee, WI

Investigational Oral Medication for RRMS
Salt Lake City, UT

Investigational Oral Medication for RRMS
Newport News, VA

Investigational Oral Medication for RRMS
Wien, VA

Investigational Oral Medication for RRMS
Richmond, VA

Investigational Oral Medication for RRMS
Bennington, VT

Investigational Oral Medication for RRMS
Bennington, VT

Investigational Oral Medication for RRMS
Nashville, TN

Investigational Oral Medication for RRMS
San Antonio, TX

Investigational Oral Medication for RRMS
Dallas, TX

Investigational Oral Medication for RRMS
Galveston, TX

Investigational Oral Medication for RRMS
Houston, TX

Investigational Oral Medication for RRMS
Round Rock, TX

Investigational Oral Medication for RRMS
East Providence, RI

Investigational Oral Medication for RRMS
Providence, RI

Investigational Oral Medication for RRMS
Cordova, TN

Investigational Oral Medication for RRMS
Franklin, TN

Investigational Oral Medication for RRMS
Knoxville, TN

Investigational Oral Medication for RRMS
Memphis, TN

Investigational Oral Medication for RRMS
Portland, OR

Investigational Oral Medication for RRMS
Erie, PA

Investigational Oral Medication for RRMS
Hershey, PA

Investigational Oral Medication for RRMS
Pittsburgh, PA

Investigational Oral Medication for RRMS
Philadelphia, PA

Investigational Oral Medication for RRMS
Pittsburg, PA

Investigational Oral Medication for RRMS
Patchogue, NY

Investigational Oral Medication for RRMS
Dayton, OH

Investigational Oral Medication for RRMS
Bellevue, OH

Investigational Oral Medication for RRMS
Cleveland, OH

Investigational Oral Medication for RRMS
Oklahoma City, OK

Investigational Oral Medication for RRMS
Medford, OR

Investigational Oral Medication for RRMS
Stony Brook, NY

Investigational Oral Medication for RRMS
Amherst, NY

Investigational Oral Medication for RRMS
Buffalo, NY

Investigational Oral Medication for RRMS
Cedarhurst, NY

Investigational Oral Medication for RRMS
Columbus, NY

Investigational Oral Medication for RRMS
New York, NY

Investigational Oral Medication for RRMS
Albuquerque, NM

Investigational Oral Medication for RRMS
Las Vegas, NV

Investigational Oral Medication for RRMS
Albany, NY

Investigational Oral Medication for RRMS
Staten Island, NY

Investigational Oral Medication for RRMS
Plainview, NY

Investigational Oral Medication for RRMS
Staten Island, NY

Investigational Oral Medication for RRMS
Charlotte, NC

Investigational Oral Medication for RRMS
Winston-Salem, NC

Investigational Oral Medication for RRMS
Lebanon, NH

Investigational Oral Medication for RRMS
Dover, NH

Investigational Oral Medication for RRMS
Lebanon, NH

Investigational Oral Medication for RRMS
Teaneck, NJ

Investigational Oral Medication for RRMS
Grand Rapids, MI

Investigational Oral Medication for RRMS
Minneapolis, MN

Investigational Oral Medication for RRMS
Saint Louis, MO

A Dose-Finding Study of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis.
Charlotte, NC

Investigational Oral Medication for RRMS
Charlotte, NC

Investigational Oral Medication for RRMS
Raleigh, NC

Investigational Oral Medication for RRMS
Worcester, MA

Investigational Oral Medication for RRMS
Boston, MA

Investigational Oral Medication for RRMS
Baltimore, MD

Investigational Oral Medication for RRMS
Farmington Hills, MI

Investigational Oral Medication for RRMS
Ann Arbor, MI

Investigational Oral Medication for RRMS
Clinton Township, MI

Investigational Oral Medication for RRMS
Louisville, KY

Investigational Oral Medication for RRMS
Shreveport, LA

Investigational Oral Medication for RRMS
Boston, MA

Investigational Oral Medication for RRMS
Hopedale, MA

Investigational Oral Medication for RRMS
Lexington, MA

Investigational Oral Medication for RRMS
Springfield, MA

Investigational Oral Medication for RRMS
Fort Wayne, IN

Investigational Oral Medication for RRMS
Indianapolis, IN

Investigational Oral Medication for RRMS
Indianapolis, IN

Investigational Oral Medication for RRMS
Wichita, KS

Investigational Oral Medication for RRMS
Kansas City, KS

Investigational Oral Medication for RRMS
Lexington, KY

Investigational Oral Medication for RRMS
Augusta, GA

Investigational Oral Medication for RRMS
Des Moines, IA

Investigational Oral Medication for RRMS
Meridian, ID

Investigational Oral Medication for RRMS
Evanston, IL

Investigational Oral Medication for RRMS
Palos Heights, IL

Investigational Oral Medication for RRMS
Maywood, IL

Investigational Oral Medication for RRMS
Vero Beach, FL

Investigational Oral Medication for RRMS
Lighthouse Point, FL

Investigational Oral Medication for RRMS
Maitland, FL

Investigational Oral Medication for RRMS
Melbourne, FL

Investigational Oral Medication for RRMS
Miami, FL

Investigational Oral Medication for RRMS
Atlanta, GA

Investigational Oral Medication for RRMS
Naples, FL

Investigational Oral Medication for RRMS
Pompano Beach, FL

Investigational Oral Medication for RRMS
Saint Petersburg, FL

Investigational Oral Medication for RRMS
Sarasota, FL

Investigational Oral Medication for RRMS
Tallahassee, FL

Investigational Oral Medication for RRMS
Tampa, FL

Investigational Oral Medication for RRMS
Boulder, CO

Investigational Oral Medication for RRMS
Colorado Springs, CO

Investigational Oral Medication for RRMS
Fort Collins, CO

Investigational Oral Medication for RRMS
New Haven, CT

Investigational Oral Medication for RRMS
Washington, DC

A Dose-Finding Study of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis.
Bradenton, FL

A Dose-Finding Study of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis.
Berkeley, CA

Investigational Oral Medication for RRMS
Sacramento, CA

Investigational Oral Medication for RRMS
San Francisco, CA

Investigational Oral Medication for RRMS
La Jolla, CA

Investigational Oral Medication for RRMS
Loma Linda, CA

Investigational Oral Medication for RRMS
Pasadena, CA


Forward
to a
friend


Trial Listings


Email Notification


Drug Directories


About Clinical Research


Additional Resources


Patient Bookstore

CenterWatch | 100 N. Washington St. | Boston | MA | 02114 | United States
To unsubscribe from this email service, click here

 

 

 

FTY720 fingolimod Novartis

Neuroscience - Novartis.com
The Neuroscience Disease Area at the Novartis Institutes for BioMedical Research ... FTY720 (fingolimod) for multiple sclerosis (MS) - Phase III clinical ...

 

 

Tysabri

Cinven drops out of race for EDT
Thomson Merger News (subscription) - London,UK
A loss of confidence in MS treatment drug Tysabri and uncertain results for trials of Bapineuzumab, an Alzheimer drug, mean it is under pressure to sell ...
See all stories on this topic

PDL Could Get $1.2B from BMS for Two Early Stage Antibodies
BioWorld Online - Atlanta,GA,USA
PDL derives antibody royalties from net sales of eight products including Avastin (bevacizumab, Genentech Inc.) and Tysabri (natalizumab, Biogen Idec Inc. ...
See all stories on this topic

Cinven drops out of EDT race
Healthcare Digital - UK
Shares lost almost half their value at the beginning of the month after Tysabri, a treatment for MS sufferers, was linked to a potentially lethal brain ...
See all stories on this topic

Equity giant pulls out of running for EDT buyout
Irish Independent - Dublin,Ireland
The focus on the auction comes after fresh concerns at Elan surrounding its leading drug and multiple sclerosis treatment, Tysabri. ...
See all stories on this topic

 

 

Chapman celebrates
Lac du Bonnet Leader - Lac du Bonnet,Manitoba,Canada
He is a top fundraiser for the annual Super Cities WALK for Multiple Sclerosis. The mayor’s roots certainly run deep in the community. ...
See all stories on this topic

 

 

 

 

A SUBTLE MAKEOVER FOR MICHELLE OBAMA
Volkskrant - Netherlands
Then a close friend from college died. So did her father, who had long suffered from multiple sclerosis; Michelle so adored him that she would curl up in his lap even as an adult. ...
See all stories on this topic

 

 

 

World-Class MS Information At The Touch Of A Button
People affected by the debilitating neurological condition multiple sclerosis (MS) now have world-class information at their fingertips thanks to a UK first by the MS Society. The charity, which is the largest of its kind supporting people affected by MS, has this week created an online library of the thousands of books, journals, papers and magazines that it has in its collection, searchable from anywhere with an internet connection.

 

 

 

 


Opexa Conducts Additional Analysis on Phase I/II Extension Study ...
istockAnalyst.com - Salem,OR,USA
... a T-cell therapy for multiple sclerosis which is in Phase IIb trials. The Company holds an exclusive worldwide license for adult multipotent stem cells ...
See all stories on this topic

North scientists in life-saving discovery
Journal Live - Newcastle upon Tyne,UK
Their work is the latest in a long line of North university success stories, with recent weeks seeing hope for rheumatoid arthritis and multiple sclerosis ...
See all stories on this topic

Scientists use cloned cells to heal injured mice
Telegraph-Journal - Saint John,New Brunswick,Canada
They used stem cells isolated from the menstrual blood of two women and cloned by a San Diego company to save the legs of eight severely injured mice. ...
See all stories on this topic


Guideline: Surgery May Be Considered For Extreme Face Pain
A new guideline developed by the American Academy of Neurology finds surgery may be considered for people who suffer from extreme, electric shock-like pain in their face and do not respond well to drugs.

 

 

Behavior Affected By False Memories: New Study
Do you know someone who claims to remember their first day of kindergarten? Or a trip they took as a toddler? While some people may be able to recall trivial details from the past, laboratory research shows that the human memory can be remarkably fragile and even inventive.

 

 

Dopamine Increased In The Human Brain By Just 1 Sleepless Night
Just one night without sleep can increase the amount of the chemical dopamine in the human brain, according to new imaging research in the August 20 issue of The Journal of Neuroscience.

 

 

The image “http://www.msanswers.ca/App_Themes/AskTheExpert_English/Images/question_buttonEN.gif” cannot be displayed, because it contains errors.

 

Symptoms and Management

Dr. Smyth

Neurologist, MS Specialist
View BIO

Q :
When you have MS can your menstrual period stop?
A :
MS is more common in women, and part of the female susceptibility to getting MS is believed to be related to female hormones. Conversely, the state of pregnancy has been shown to help protect against MS relapses.
Many women report that their MS symptoms worsen just before their menstrual period and stop once their menstrual period has stopped.
Multiple sclerosis usually doesn’t cause your menstrual period to stop. However, many of the medications used in MS can affect your menstrual period. SSRI’s (a family of antidepressant drugs) can cause irregular periods. Sometimes, chemotherapies such as mitoxantrone or cyclophosphamide are used for aggressive MS. Those chemotherapies can stop your menstrual periods. Beta-interferons (Avonex ®, Betaseron ®, and Rebif®) can cause spotting between periods.
If your menstrual period has stopped, I would follow up with your family doctor and your neurologist to look for other causes of menstrual irregularities not related to MS, and to review your medications.
8/22/2008 4:31:17 PM
More answers from Dr. Penelope Smyth
More answers in the category: Symptoms and Management

 

 

http://www.msanswers.ca/QuestionView.aspx?L=2&QID=2132

 

 

 

Man gets $350,000 heart bypass by stealing friend's identity

By Anne Zieger
Comment | Forward

John Parsons apparently believed he would die without heart bypass surgery. To get it, the uninsured 57-year-old ex-convict took a step that has hospital officials shaking their heads--he managed to pass himself off as a mentally-disabled friend and, using the friend's Medicaid card, obtained the surgery. Now, officials at Chicago's Northwestern Memorial Hospital are stuck with a big bill and a lot of questions as to how Parsons pulled it off.

According to the authorities, Parsons got the surgery at Northwestern in 2007, generating about $350,000 in expenses. When bills started arriving at the home of the friend, Philip Johnson, Johnson's live-in caregiver discovered the alleged scam and notified officials. Parsons has since admitted stealing Johnson's identity. Northwestern, for its part, has agreed to cover the cost of the surgery so Johnson won't be responsible for it.

What has healthcare officials puzzled is the extent of the apparent deception. To get the heart bypass, doctors would have needed a lot of clinical information, including patient blood type, cardiac history, medical history and more, records that would be very difficult to fake, notes CMS spokesman Jeff Nelligan. Northwestern continues to investigate the incident.

To learn more about the alleged scam:
- read this Chicago Tribune piece

Read more about: Jeff Nelligan, Philip Johnson, Northwestern Memorial Hospital, Medicaid

 

Caregivers / Homecare News
More Than 10 Percent Of Older Americans Suffer Mistreatment According To U. Of Chicago Study
About 13 percent of elderly Americans are mistreated, most commonly by someone who verbally mistreats or financially takes advantage of them, according to a University of Chicago study that is the first comprehensive look at elder mistreatment in the country.

 

 

ACS: Ear Infections in Childhood Linked to Obesity in Grownups CME (with audio)
PHILADELPHIA -- Children who develop moderate to severe middle ear infections may suffer damage to a critical taste-sensing nerve that leaves them prone to overeating and excessive weight, researchers said here. full story

http://www.medpagetoday.com/Pediatrics/GeneralPediatrics/tb/10609

 

 

 

 

Dogs aren't stupid wolves; they are much smarter Premium
Dogs have come a long way from their closest relative, the wolf. Living with humans seems to have rubbed off on their intellects says Kate Douglas

What would life be like on a two-star planet? Premium
Marcus Chown finds out whether multiple-star systems could exist and what life would be like there

Looming water crisis simply a management problem Premium
There's plenty to go round, so why is the world facing a water crisis, asks Jonathan Chenoweth

The power of the placebo effect Premium
When Michael Brooks went in search of the placebo effect, he was shocked by what he found

First red blood cells grown in the lab
http://email.newscientist.com/cgi-bin1/DM/y/nBaby0MQ8Vq0keh0FEfb0Eb

 

 

high blood pressure

The You Docs: The easiest way to get healthier tonight
Seattle Post Intelligencer - USA
A group of 32- to 59-year-olds who got fewer than five hours of sleep a night for several years were twice as likely to develop high blood pressure as those ...
See all stories on this topic

 

 

See Clearly with Fish Oil
Stop Aging Now - Washington,DC,USA
By Carey Rossi Keep your eyes focused and your sight strong by consuming large amounts of omega-3 fatty acids, suggests a new meta-analysis—the gold ...
See all stories on this topic

 

probiotics

Taking Probiotics Greatly Reduces Infections in Athletes
Natural News.com - Phoenix,AZ,USA
(NaturalNews) Athletes who took probiotic supplements suffered fewer infections and recovered more quickly than those who did not, in a study conducted by ...
See all stories on this topic

Probiotics As Functional Food For Health
Gorkhapatra - Kathmandu,Nepal
Probiotics are currently defined as live microorganisms which when consumed in sufficient quantity confer health benefits to the host. ...
See all stories on this topic

Cranberry juice
SheKnows.com - Scottsdale,AZ,USA
But new research also suggests that cranberry juice is just as effective as probiotics in maintaining good digestive health, too. ...
See all stories on this topic

 

 

vitamin D

Top 10 Myths About Vitamin D
RedOrbit - Dallas,TX,USA
By Skowron, Jared M Myth 1: Vitamin D is a vitamin. The Truth: Vitamin D is a hormone. It's derived from cholesterol. It activates cellular processes and ...
See all stories on this topic

If you don't get enough vitamin D, could it kill you?
Orlando Sentinel - Orlando,FL,USA
A lack of vitamin D has been found in some studies to play an unrecognized role in death among people suffering from a variety of medical problems, ...
See all stories on this topic

 

 

Significant Long Term Benefit For Low Back Pain Revealed By Major Study
A major study led by a Southampton researcher has found significant evidence that the Alexander Technique can provide long-term benefit for people with chronic or recurrent low back pain.The study, one of the first of its kind, is being published online today by the BMJ at BMJ.

 

The image “http://pharmalive.com/images/logo.gif” cannot be displayed, because it contains errors.

EU OKs Cymbalta for Generalized Anxiety Disorder
Eli Lilly and Germany's Boehringer Ingelheim said today the European Commission has approved the use of Cymbalta for the treatment of Generalized Anxiety Disorder. This approval is the fourth for duloxetine in Europe. According to PharmaLive's eKnowledgeBase, Cymbalta earned $2.1 billion last year.
read more...

 

 

SPOTLIGHT ON... As measles cases mount, officials blame fear of autism

Despite a seeming lack of sound evidence supporting their contention, a growing number of parents have come to believe that childhood vaccinations can cause autism. Officials now believe that a ricochet effect from such fears has appeared. Public health data has come demonstrating that more people had measles infections in the first seven months of this year than during any comparable period since 1996, many of whom were unvaccinated because of either their own beliefs or those of their parents. The question is, what can public health leaders do about it? Article

0 Comments:

Post a Comment

Links to this post:

Create a Link

<< Home